Table 1.
Descriptive statistics for NCDB invasive epithelial ovarian cancer cohort based on era of diagnosis (1998–2002, 2003–2007) (N = 111,956).
| Risk factor | All
|
Era of diagnosis 1998–2002
|
Era of diagnosis 2003–2007
|
p-Value | |||
|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | ||
| Patient characteristics | |||||||
| Age (mean, SD) | 62.29 | 14.03 | 62.32 | 14.14 | 62.27 | 13.92 | 0.6059 |
| <60 years | 48,215 | 43.07 | 23,518 | 42.47 | 24,697 | 43.65 | <.0001 |
| 60–75 years | 41,013 | 36.63 | 20,636 | 37.26 | 20,377 | 36.02 | |
| >75 years | 22,728 | 20.30 | 11,226 | 20.27 | 11,502 | 20.33 | |
| Race | <.0001 | ||||||
| White | 99,265 | 88.66 | 49,491 | 89.37 | 49,774 | 87.98 | |
| African Americans | 11,110 | 9.92 | 5214 | 9.41 | 5896 | 10.42 | |
| Unknown | 1581 | 1.41 | 675 | 1.22 | 906 | 1.60 | |
| Median household income — 2000 | <.0001 | ||||||
| $46,000 + | 43,341 | 38.71 | 21,145 | 38.18 | 22,196 | 39.23 | |
| $35,000–$45,999 | 29,997 | 26.79 | 14,965 | 27.02 | 15,032 | 26.57 | |
| <$35,000 | 32,163 | 28.73 | 16,337 | 29.50 | 15,826 | 27.97 | |
| Missing | 6455 | 5.77 | 2933 | 5.30 | 3522 | 6.23 | |
| Primary payer at diagnosis | <.0001 | ||||||
| Private insurance | 18,059 | 16.13 | 10,738 | 19.39 | 7321 | 12.94 | |
| Medicare/medicare supplements | 44,727 | 39.95 | 22,109 | 39.92 | 22,618 | 39.98 | |
| Managed care/TRICARE/military | 35,813 | 31.99 | 15,718 | 28.38 | 20,095 | 35.52 | |
| Medicaid/federal insurance programs/public health service | 4991 | 4.46 | 2213 | 4.00 | 2778 | 4.91 | |
| Not insured — self pay | 4344 | 3.88 | 1984 | 3.58 | 2360 | 4.17 | |
| Missing: insurance status unknown | 4022 | 3.59 | 2618 | 4.73 | 1404 | 2.48 | |
| Tumor characteristics | |||||||
| Tumor stage | <.0001 | ||||||
| Stage I | 19,516 | 17.43 | 9995 | 18.05 | 9521 | 16.83 | |
| Stage II | 7941 | 7.09 | 4042 | 7.30 | 3899 | 6.89 | |
| Stage III | 43,918 | 39.23 | 21,888 | 39.52 | 22,030 | 38.94 | |
| Stage IV | 27,587 | 24.64 | 14,605 | 26.37 | 12,982 | 22.95 | |
| UNK | 9756 | 8.71 | 3783 | 6.83 | 5973 | 10.56 | |
| NA | 53 | 0.05 | 16 | 0.03 | 37 | 0.07 | |
| Improperly staged | 3185 | 2.84 | 1051 | 1.90 | 2134 | 3.77 | |
| Hospital ovarian cancer volume/year | <.0001 | ||||||
| 1–7 cases/year | 28,122 | 25.12 | 14,961 | 27.02 | 13,161 | 23.26 | |
| 8–16 cases/year | 27,946 | 24.96 | 13,764 | 24.85 | 14,182 | 25.07 | |
| 17–28 cases/year | 27,839 | 24.87 | 13,216 | 23.86 | 14,623 | 25.85 | |
| ≥29 cases/year | 28,049 | 25.05 | 13,439 | 24.27 | 14,610 | 25.82 | |
| Facility type | <.0001 | ||||||
| Community cancer program | 13,777 | 12.31 | 7209 | 13.02 | 6568 | 11.61 | |
| Comprehensive community cancer program | 49,977 | 44.64 | 24,960 | 45.07 | 25,017 | 44.22 | |
| Academic/research program (includes NCI-designated comprehensive cancer centers) | 48,202 | 43.05 | 23,211 | 41.91 | 24,991 | 44.17 | |
| Total | 111,956 | 100.00 | 55,380 | 100.00 | 56,576 | 100.00 | |